82_FR_20444 82 FR 20362 - National Cancer Institute; Notice of Closed Meetings

82 FR 20362 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 82 (May 1, 2017)

Page Range20362-20363
FR Document2017-08704

Federal Register, Volume 82 Issue 82 (Monday, May 1, 2017) 
[Federal Register Volume 82, Number 82 (Monday, May 1, 2017)]
[Notices]
[Pages 20362-20363]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-08704]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; IMAT R21 Review.
    Date: May 17, 2017.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; IMAT R33 Review.
    Date: May 18, 2017.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W114, Bethesda, MD 20892-9750, 240-276-6371, 
[email protected].


[[Page 20363]]


    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 & Omnibus R03: SEP-2.
    Date: June 5, 2017.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Arlington Gateway Hotel, 801 N. Glebe Road, 
Arlington, VA 22203.
    Contact Person: Robert S. Coyne, Ph.D., Scientific Review 
Officer, Special Review Branch Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W236, Bethesda, MD 20892-9750, 240-276-5120, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project I (P01).
    Date: June 7-8, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Bethesda, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Clinical and Translational R21 & Omnibus R03: SEP 6.
    Date: June 13-14, 2017.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Bethesda, MD 20892-9750, 240-276-5122, 
[email protected].

    Name of Committee: National Cancer Institute, Initial Review 
Group; Subcommittee F--Institutional Training and Education.
    Date: June 13, 2017.
    Time: 12:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750 (Telephone 
Conference Call).
    Contact Person: Timothy C. Meeker, MD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Youth Enjoy Science (YES).
    Date: June 21, 2017.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W530, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Shamala K. Srinivas, Ph.D., Scientific Review 
Officer, Office of Referral, Review, and Program Coordination, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-9750, 240-
276-6430, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Canine Immunotherapy Trials RFA CA-17-001 (U01) & RFA CA-17-
002 (U24).
    Date: June 22, 2017.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 1E030, Bethesda, MD 20892-9750 (Telephone 
Conference Call).
    Contact Person: Caterina Bianco, MD, Ph.D., Acting Chief, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6459, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R01 Meeting Teleconference.
    Date: June 22, 2017.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W618, Bethesda, MD 20892-9750 (Telephone 
Conference Call).
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W618, Bethesda, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; PDAC U01 Review.
    Date: June 26, 2017.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W126, Bethesda, MD 20892-9750 (Telephone 
Conference Call).
    Contact Person: Caron A. Lyman, Ph.D., Scientific Review 
Officer, Research Program Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R03 & Clinical and Translational R21: SEP-7.
    Date: June 28-29, 2017.
    Time: 8:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel and Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Beyeong-Chul Lee, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750, 240-276-7755, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; CIMAC and CIDC U24 Review.
    Date: July 13, 2017.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Bethesda, MD 20892-9750, (Telephone 
Conference Call).
    Contact Person: Majed Hamawy, Ph.D., Scientific Review Officer, 
Resources and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W120, Bethesda, MD 20892-9750, 240-276-6457, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: April 25, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-08704 Filed 4-28-17; 8:45 am]
 BILLING CODE 4140-01-P

20362 Federal Register / Vol. 82, No. 82 / Monday, May 1, 2017 / Notices As required by 45 CFR part 75 for noncompliance, including HHS mission to protect and advance the Appendix XII of the Uniform Guidance, suspension or debarment (See 2 CFR physical and mental health of the non-federal entities (NFEs) are required parts 180 & 376 and 31 U.S.C. 3321). American people. to disclose in FAPIIS any information Dated: April 24, 2017. VII. Agency Contacts about criminal, civil, and administrative Elizabeth A. Fowler, proceedings, and/or affirm that there is 1. Questions on the programmatic issues may be directed to: Roselyn Tso, Deputy Director for Management Operations, no new information to provide. This Indian Health Service. applies to NFEs that receive Federal Acting Director, Office of Direct Service [FR Doc. 2017–08775 Filed 4–28–17; 8:45 am] awards (currently active grants, and Contracting Tribes, Indian Health Service, 5600 Fishers Lane, Mail Stop BILLING CODE 4165–16–P cooperative agreements, and procurement contracts) greater than 08E17, Rockville, MD 20857, $10,000,000 for any period of time Telephone: (301) 443–1104, Email: DEPARTMENT OF HEALTH AND during the period of performance of an roselyn.tso@ihs.gov. 2. Questions on grants management HUMAN SERVICES award/project. and fiscal matters may be directed to: National Institutes of Health Mandatory Disclosure Requirements Ms. Vanietta Armstrong, Grants As required by 2 CFR part 200 of the Management Specialist, Indian Health National Cancer Institute; Notice of Uniform Guidance, and the HHS Service, OMS/DGM, 5600 Fishers Lane, Closed Meetings implementing regulations at 45 CFR part Mail Stop 09E70, Rockville, MD 20857, 75, effective January 1, 2016, the IHS Telephone: (301) 443–4792, Fax: (301) Pursuant to section 10(d) of the must require a non-federal entity or an 594–0899, Email: vanietta.armstrong@ Federal Advisory Committee Act, as applicant for a Federal award to ihs.gov. amended (5 U.S.C. App.), notice is disclose, in a timely manner, in writing 3. Questions on systems matters may hereby given of the following meetings. to the IHS or pass-through entity all be directed to: Mr. Paul Gettys, Grant The meetings will be closed to the violations of Federal criminal law Systems Coordinator, 5600 Fishers public in accordance with the involving fraud, bribery,or gratutity Lane, Mail Stop 09E70, Rockville, MD provisions set forth in sections violations potentially affecting the 20857, Phone: (301) 443–2114; or the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Federal award. DGM main line (301) 443–5204, Fax: as amended. The grant applications and Submission is required for all (301) 594–0899, E-Mail: Paul.Gettys@ the discussions could disclose applicants and recipients, in writing, to ihs.gov. confidential trade secrets or commercial the IHS and to the HHS Office of property such as patentable material, VIII. Other Information and personal information concerning Inspector General all information related to violations of Federal criminal The Public Health Service strongly individuals associated with the grant law involving fraud, bribery, or gratuity encourages all cooperative agreement applications, the disclosure of which violations potentially affecting the and contract recipients to provide a would constitute a clearly unwarranted Federal award. 45 CFR 75.113. smoke-free workplace and promote the invasion of personal privacy. Disclosures must be sent in writing to: non-use of all tobacco products. In Name of Committee: National Cancer U.S. Department of Health and Human addition, Public Law 103–227, the Pro- Institute Special Emphasis Panel; IMAT R21 Services, Indian Health Service, Children Act of 1994, prohibits smoking Review. Division of Grants Management, ATTN: in certain facilities (or in some cases, Date: May 17, 2017. any portion of the facility) in which Time: 10:00 a.m. to 6:00 p.m. Robert Tarwater, Director, 5600 Fishers Agenda: To review and evaluate grant Lane, Mailstop 09E70, Rockville, regular or routine education, library, applications. Maryland 20857. day care, health care, or early childhood Place: National Cancer Institute Shady (Include ‘‘Mandatory Grant development services are provided to Grove, 9609 Medical Center Drive, Room Disclosures’’ in subject line) children. This is consistent with the 7W114, Rockville, MD 20850 (Telephone Office: (301) 443–5204. HHS mission to protect and advance the Conference Call). Fax: (301) 594–0899. physical and mental health of the Contact Person: Jeffrey E. DeClue, Ph.D., Email: Robert.Tarwater@ihs.gov. American people. Scientific Review Officer, Research AND Dated: April 24, 2017. Technology and Contract Review Branch, U.S. Department of Health and RADM Chris Buchanan, R.E.H.S., Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Human Services, Office of Inspector M.P.H. Drive, Room 7W114, Bethesda, MD 20892– General, ATTN: Mandatory Grant Assistant Surgeon General, USPHS 9750, 240–276–6371, decluej@mail.nih.gov. Disclosures, Intake Coordinator, 330 Acting Director Name of Committee: National Cancer Independence Avenue SW., Cohen Indian Health Service Institute Special Emphasis Panel; IMAT R33 Building, Room 5527, Washington, DC VIII. Other Information Review. 20201. Date: May 18, 2017. URL: http://oig.hhs.gov/fraud/ The PHS strongly encourages all Time: 11:00 a.m. to 6:00 p.m. reportfraud/index.asp. cooperative agreement and contract Agenda: To review and evaluate grant (Include ‘‘Mandatory Grant recipients to provide a smoke-free applications. Disclosures’’ in subject line). workplace and promote the non-use of Place: National Cancer Institute Shady Fax: (202) 205–0604 (Include all tobacco products. In addition, Public Grove, 9609 Medical Center Drive, Room Law 103–227, the Pro-Children Act of 7W114, Rockville, MD 20850 (Telephone srobinson on DSK5SPTVN1PROD with NOTICES ‘‘Mandatory Grant Disclosures’’ in 1994, prohibits smoking in certain Conference Call). subject line) or Contact Person: Jeffrey E. DeClue, Ph.D., Email: facilities (or in some cases, any portion Scientific Review Officer, Research MandatoryGranteeDisclosures@ of the facility) in which regular or Technology and Contract Review Branch, oig.hhs.gov. routine education, library, day care, Division of Extramural Activities, National Failure to make required disclosures health care, or early childhood Cancer Institute, NIH, 9609 Medical Center can result in any of the remedies development services are provided to Drive, Room 7W114, Bethesda, MD 20892– described in 45 CFR 75.371 Remedies children. This is consistent with the 9750, 240–276–6371, decluej@mail.nih.gov. VerDate Sep<11>2014 20:35 Apr 28, 2017 Jkt 241001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\01MYN1.SGM 01MYN1

Federal Register / Vol. 82, No. 82 / Monday, May 1, 2017 / Notices 20363 Name of Committee: National Cancer Time: 1:00 p.m. to 4:00 p.m. Place: Bethesda North Marriott Hotel and Institute Special Emphasis Panel; NCI Agenda: To review and evaluate grant Conference Center, 5701 Marinelli Road, Clinical and Translational R21 & Omnibus applications. North Bethesda, MD 20852. R03: SEP–2. Place: National Cancer Institute Shady Contact Person: Beyeong-Chul Lee, Ph.D., Date: June 5, 2017. Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Resources and Time: 8:00 a.m. to 4:00 p.m. 7W530, Rockville, MD 20850 (Telephone Training Review Branch, Division of Agenda: To review and evaluate grant Conference Call). Extramural Activities, National Cancer applications. Contact Person: Shamala K. Srinivas, Institute, NIH, 9609 Medical Center Drive, Place: The Westin Arlington Gateway Ph.D., Scientific Review Officer, Office of Room 7W238, Bethesda, MD 20892–9750, Hotel, 801 N. Glebe Road, Arlington, VA Referral, Review, and Program Coordination, 240–276–7755, byeong-chel.lee@nih.gov. 22203. Division of Extramural Activities, National Name of Committee: National Cancer Contact Person: Robert S. Coyne, Ph.D., Cancer Institute, NIH, 9609 Medical Center Institute Special Emphasis Panel; CIMAC and Scientific Review Officer, Special Review Drive, Room 7W530, Bethesda, MD 20892– CIDC U24 Review. Branch Division of Extramural Activities, 9750, 240–276–6430, shamala@mail.nih.gov. Date: July 13, 2017. National Cancer Institute, NIH, 9609 Medical Name of Committee: National Cancer Time: 11:00 a.m. to 5:00 p.m. Center Drive, Room 7W236, Bethesda, MD Institute Special Emphasis Panel; Canine Agenda: To review and evaluate grant 20892–9750, 240–276–5120, robert.coyne@ Immunotherapy Trials RFA CA–17–001 applications. nih.gov. (U01) & RFA CA–17–002 (U24). Place: National Cancer Institute Shady Name of Committee: National Cancer Date: June 22, 2017. Grove, 9609 Medical Center Drive, Room Institute Special Emphasis Panel; NCI Time: 9:00 a.m. to 5:00 p.m. 7W030, Bethesda, MD 20892–9750, Program Project I (P01). Agenda: To review and evaluate grant (Telephone Conference Call). Date: June 7–8, 2017. applications. Contact Person: Majed Hamawy, Ph.D., Time: 8:00 a.m. to 12:00 p.m. Place: National Cancer Institute Shady Scientific Review Officer, Resources and Agenda: To review and evaluate grant Grove, 9609 Medical Center Drive, Room Training Review Branch, Division of applications. 1E030, Bethesda, MD 20892–9750 Extramural Activities, National Cancer (Telephone Conference Call). Institute, NIH, 9609 Medical Center Drive, Place: Bethesda Marriott Suites, 6711 Contact Person: Caterina Bianco, MD, Room 7W120, Bethesda, MD 20892–9750, Democracy Boulevard, Bethesda, MD 20817. Ph.D., Acting Chief, Resources and Training 240–276–6457, mh101v@nih.gov. Contact Person: Sanita Bharti, Ph.D., Review Branch, Division of Extramural (Catalogue of Federal Domestic Assistance Scientific Review Officer, Research Program Activities, National Cancer Institute, NIH, Program Nos. 93.392, Cancer Construction; Review Branch, Division of Extramural 9609 Medical Center Drive, Room 7W110, 93.393, Cancer Cause and Prevention Activities, National Cancer Institute, NIH, Bethesda, MD 20892–9750, 240–276–6459, Research; 93.394, Cancer Detection and 9609 Medical Center Drive, Room 7W618, biancoc@mail.nih.gov. Diagnosis Research; 93.395, Cancer Bethesda, MD 20892–9750, 240–276–5909, sanitab@mail.nih.gov. Name of Committee: National Cancer Treatment Research; 93.396, Cancer Biology Institute Special Emphasis Panel; NCI R01 Research; 93.397, Cancer Centers Support; Name of Committee: National Cancer Meeting Teleconference. 93.398, Cancer Research Manpower; 93.399, Institute Special Emphasis Panel; NCI Date: June 22, 2017. Cancer Control, National Institutes of Health, Clinical and Translational R21 & Omnibus Time: 11:00 a.m. to 3:00 p.m. HHS) R03: SEP 6. Agenda: To review and evaluate grant Date: June 13–14, 2017. Dated: April 25, 2017. applications. Time: 8:00 a.m. to 12:00 p.m. Place: National Cancer Institute Shady Melanie J. Pantoja, Agenda: To review and evaluate grant Grove, 9609 Medical Center Drive, Room Program Analyst, Office of Federal Advisory applications. 7W618, Bethesda, MD 20892–9750 Committee Policy. Place: Gaithersburg Marriott (Telephone Conference Call). [FR Doc. 2017–08704 Filed 4–28–17; 8:45 am] Washingtonian Center, 9751 Washingtonian Contact Person: Sanita Bharti, Ph.D., Boulevard, Gaithersburg, MD 20878. BILLING CODE 4140–01–P Scientific Review Officer, Research Program Contact Person: Hasan Siddiqui, Ph.D., Review Branch, Division of Extramural Scientific Review Officer, Special Review Activities, National Cancer Institute, NIH, Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W618, DEPARTMENT OF HEALTH AND National Cancer Institute, NIH, 9609 Medical Bethesda, MD 20892–9750, 240–276–5909, HUMAN SERVICES Center Drive, Room 7W240, Bethesda, MD sanitab@mail.nih.gov. 20892–9750, 240–276–5122, hasan.siddiqui@ National Institutes of Health Name of Committee: National Cancer nih.gov. Institute Special Emphasis Panel; PDAC U01 Name of Committee: National Cancer Submission for OMB Review; 30-Day Review. Institute, Initial Review Group; Date: June 26, 2017. Comment Request; Generic Clearance Subcommittee F—Institutional Training and Time: 11:00 a.m. to 5:00 p.m. for Surveys of Customers and Partners Education. Agenda: To review and evaluate grant of the Office of Extramural Research of Date: June 13, 2017. applications. the National Institutes of Health Time: 12:00 p.m. to 4:30 p.m. Place: National Cancer Institute Shady Agenda: To review and evaluate grant Grove, 9609 Medical Center Drive, Room AGENCY: National Institutes of Health, applications. 7W126, Bethesda, MD 20892–9750 Department of Health and Human Place: National Cancer Institute Shady (Telephone Conference Call). Services. Grove, 9609 Medical Center Drive, Room Contact Person: Caron A. Lyman, Ph.D., ACTION: Notice. 7W606, Bethesda, MD 20892–9750 Scientific Review Officer, Research Program (Telephone Conference Call). Review Branch, Division of Extramural SUMMARY: In compliance with the Contact Person: Timothy C. Meeker, MD, Activities, National Cancer Institute, NIH, Paperwork Reduction Act of 1995, the Scientific Review Officer, Resources and 9609 Medical Center Drive, Room 7W126, National Institutes of Health (NIH) has Training Review Branch, Division of Bethesda, MD 20892–9750, 240–276–6348, submitted to the Office of Management srobinson on DSK5SPTVN1PROD with NOTICES Extramural Activities, National Cancer lymanc@mail.nih.gov. Institute, NIH, 9609 Medical Center Drive, and Budget (OMB) a request for review Name of Committee: National Cancer and approval of the information Room 7W606, Bethesda, MD 20892–9750, Institute Special Emphasis Panel; NCI R03 & 240–276–6464, meekert@mail.nih.gov. Clinical and Translational R21: SEP–7. collection listed below. This proposed Name of Committee: National Cancer Date: June 28–29, 2017. information collection was previously Institute Special Emphasis Panel; Youth Time: 8:00 a.m. to 2:00 p.m. published in the Federal Register on Enjoy Science (YES). Agenda: To review and evaluate grant February 16, 2017, and allowed 60-days Date: June 21, 2017. applications. for public comment. No public VerDate Sep<11>2014 20:35 Apr 28, 2017 Jkt 241001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\01MYN1.SGM 01MYN1


Document Created: 2017-04-29 03:16:14
Document Modified: 2017-04-29 03:16:14
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMay 17, 2017.
FR Citation82 FR 20362 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR